全文获取类型
收费全文 | 7916篇 |
免费 | 512篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 46篇 |
儿科学 | 117篇 |
妇产科学 | 150篇 |
基础医学 | 1150篇 |
口腔科学 | 302篇 |
临床医学 | 722篇 |
内科学 | 1712篇 |
皮肤病学 | 379篇 |
神经病学 | 957篇 |
特种医学 | 424篇 |
外科学 | 1036篇 |
综合类 | 34篇 |
预防医学 | 337篇 |
眼科学 | 130篇 |
药学 | 472篇 |
中国医学 | 2篇 |
肿瘤学 | 501篇 |
出版年
2023年 | 44篇 |
2022年 | 81篇 |
2021年 | 187篇 |
2020年 | 143篇 |
2019年 | 147篇 |
2018年 | 151篇 |
2017年 | 136篇 |
2016年 | 216篇 |
2015年 | 228篇 |
2014年 | 283篇 |
2013年 | 364篇 |
2012年 | 647篇 |
2011年 | 605篇 |
2010年 | 382篇 |
2009年 | 351篇 |
2008年 | 608篇 |
2007年 | 607篇 |
2006年 | 588篇 |
2005年 | 574篇 |
2004年 | 480篇 |
2003年 | 436篇 |
2002年 | 441篇 |
2001年 | 87篇 |
2000年 | 45篇 |
1999年 | 92篇 |
1998年 | 97篇 |
1997年 | 80篇 |
1996年 | 45篇 |
1995年 | 44篇 |
1994年 | 27篇 |
1993年 | 31篇 |
1992年 | 22篇 |
1991年 | 24篇 |
1990年 | 16篇 |
1989年 | 9篇 |
1988年 | 17篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 6篇 |
1984年 | 12篇 |
1982年 | 8篇 |
1981年 | 6篇 |
1980年 | 9篇 |
1979年 | 4篇 |
1975年 | 7篇 |
1973年 | 9篇 |
1972年 | 5篇 |
1971年 | 4篇 |
1970年 | 5篇 |
1969年 | 6篇 |
排序方式: 共有8471条查询结果,搜索用时 15 毫秒
61.
Haitham Elbardisi Ahmad Majzoub Christiana Daniel Fadwa Al.Ali Mohamed Elesnawi Kareim Khalafalla Ashok Agarwal Ralf Henkel Alia Alattar Ibrahim Al-Emadi Mohamed Arafa 《Andrologia》2021,53(8):e14135
In this study, we investigated the prevalence of sexual dysfunction among males with advanced chronic kidney disease and the effect of treating hyperprolactinemia among these patients. In this prospective study, patients were assessed with history, physical examination, hormonal assessment, and two questionnaires, IIEF and AIPE. Patients with hyperprolactinemia received treatment with cabergoline 0.5 mg once per week for 6 months and were re-evaluated. A total of 102 patients were included in this study, 75 (73.53%) were on hemodialysis, 13 (12.75%) on peritoneal dialysis and 14 (13.73%) on medical treatment alone. Ninety (88.24%) patients had premature ejaculation, 85 (83.33%) had anything from mild-to-moderate-to-severe erectile dysfunction. The incidence of hypogonadism and hyperprolactinemia was 34.4%. Patients treated with cabergoline (n = 26) showed a significant increase in LH levels (p = .003) and a significant decrease in prolactin levels (p = .003). Testosterone levels and the incidence of erectile dysfunction or premature ejaculation did not improve significantly. There is a high incidence of sexual dysfunction among patients. Treatment of hyperprolactinemia is effective in correcting prolactin levels, but does not improve erectile dysfunction or premature ejaculation. Therefore, treating hyperprolactinemia is not an overall effective treatment for erectile dysfunction in these patients. 相似文献
62.
Julian Stürznickel Tim Rolvien Alena Delsmann Sebastian Butscheidt Florian Barvencik Stefan Mundlos Thorsten Schinke Uwe Kornak Michael Amling Ralf Oheim 《Journal of bone and mineral research》2021,36(2):271-282
Reduced bone mineral density (BMD; ie, Z-score ≤−2.0) occurring at a young age (ie, premenopausal women and men <50 years) in the absence of secondary osteoporosis is considered early-onset osteoporosis (EOOP). Mutations affecting the WNT signaling pathway are of special interest because of their key role in bone mass regulation. Here, we analyzed the effects of relevant LRP5 and LRP6 variants on the clinical phenotype, bone turnover, BMD, and bone microarchitecture. After exclusion of secondary osteoporosis, EOOP patients (n = 372) were genotyped by gene panel sequencing, and segregation analysis of variants in LRP5/LRP6 was performed. The clinical assessment included the evaluation of bone turnover parameters, BMD by dual-energy X-ray absorptiometry, and microarchitecture via high-resolution peripheral quantitative computed tomography (HR-pQCT). In 50 individuals (31 EOOP index patients, 19 family members), relevant variants affecting LRP5 or LRP6 were detected (42 LRP5 and 8 LRP6 variants), including 10 novel variants. Seventeen variants were classified as disease causing, 14 were variants of unknown significance, and 19 were BMD-associated single-nucleotide polymorphisms (SNPs). One patient harbored compound heterozygous LRP5 mutations causing osteoporosis-pseudoglioma syndrome. Fractures were reported in 37 of 50 individuals, consisting of vertebral (18 of 50) and peripheral (29 of 50) fractures. Low bone formation was revealed in all individuals. A Z-score ≤−2.0 was detected in 31 of 50 individuals, and values at the spine were significantly lower than those at the hip (−2.1 ± 1.3 versus −1.6 ± 0.8; p = .003). HR-pQCT analysis (n = 34) showed impaired microarchitecture in trabecular and cortical compartments. Significant differences regarding the clinical phenotype were detectable between index patients and family members but not between different variant classes. Relevant variants in LRP5 and LRP6 contribute to EOOP in a substantial number of individuals, leading to a high number of fractures, low bone formation, reduced Z-scores, and impaired microarchitecture. This detailed skeletal characterization improves the interpretation of known and novel LRP5 and LRP6 variants. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). 相似文献
63.
Die Anaesthesiologie - 相似文献
64.
Carlos R Ferreira Dillon Kavanagh Ralf Oheim Kristin Zimmerman Julian Stürznickel Xiaofeng Li Paul Stabach R Luke Rettig Logan Calderone Colin MacKichan Aaron Wang Hunter A Hutchinson Tracy Nelson Steven M Tommasini Simon von Kroge Imke AK Fiedler Ethan R Lester Gilbert W Moeckel Björn Busse Thorsten Schinke Thomas O Carpenter Michael A Levine Mark C Horowitz Demetrios T Braddock 《Journal of bone and mineral research》2021,36(5):942-955
Inactivating mutations in human ecto-nucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) may result in early-onset osteoporosis (EOOP) in haploinsufficiency and autosomal recessive hypophosphatemic rickets (ARHR2) in homozygous deficiency. ARHR2 patients are frequently treated with phosphate supplementation to ameliorate the rachitic phenotype, but elevating plasma phosphorus concentrations in ARHR2 patients may increase the risk of ectopic calcification without increasing bone mass. To assess the risks and efficacy of conventional ARHR2 therapy, we performed comprehensive evaluations of ARHR2 patients at two academic medical centers and compared their skeletal and renal phenotypes with ENPP1-deficient Enpp1asj/asj mice on an acceleration diet containing high phosphate treated with recombinant murine Enpp1-Fc. ARHR2 patients treated with conventional therapy demonstrated improvements in rickets, but all adults and one adolescent analyzed continued to exhibit low bone mineral density (BMD). In addition, conventional therapy was associated with the development of medullary nephrocalcinosis in half of the treated patients. Similar to Enpp1asj/asj mice on normal chow and to patients with mono- and biallelic ENPP1 mutations, 5-week-old Enpp1asj/asj mice on the high-phosphate diet exhibited lower trabecular bone mass, reduced cortical bone mass, and greater bone fragility. Treating the Enpp1asj/asj mice with recombinant Enpp1-Fc protein between weeks 2 and 5 normalized trabecular bone mass, normalized or improved bone biomechanical properties, and prevented the development of nephrocalcinosis and renal failure. The data suggest that conventional ARHR2 therapy does not address low BMD inherent in ENPP1 deficiency, and that ENPP1 enzyme replacement may be effective for correcting low bone mass in ARHR2 patients without increasing the risk of nephrocalcinosis. © 2021 American Society for Bone and Mineral Research (ASBMR). 相似文献
65.
66.
Notfall + Rettungsmedizin - Das akute Koronarsyndrom ist der häufigste Grund für einen Rettungsdiensteinsatz in Deutschland. So resultieren in etwa 20–25 % aller Einsätze... 相似文献
67.
Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3 总被引:11,自引:0,他引:11
Sindhu Rajan Regina Preisig-Müller Erhard Wischmeyer† Ralf Nehring† Peter J. Hanley Vijay Renigunta Boris Musset Günter Schlichthörl Christian Derst reas Karschin† Jürgen Daut 《The Journal of physiology》2002,545(1):13-26
The two-pore-domain potassium channels TASK-1, TASK-3 and TASK-5 possess a conserved C-terminal motif of five amino acids. Truncation of the C-terminus of TASK-1 strongly reduced the currents measured after heterologous expression in Xenopus oocytes or HEK293 cells and decreased surface membrane expression of GFP-tagged channel proteins. Two-hybrid analysis showed that the C-terminal domain of TASK-1, TASK-3 and TASK-5, but not TASK-4, interacts with isoforms of the adapter protein 14-3-3. A pentapeptide motif at the extreme C-terminus of TASK-1, RRx(S/T)x, was found to be sufficient for weak but significant interaction with 14-3-3, whereas the last 40 amino acids of TASK-1 were required for strong binding. Deletion of a single amino acid at the C-terminal end of TASK-1 or TASK-3 abolished binding of 14-3-3 and strongly reduced the macroscopic currents observed in Xenopus oocytes. TASK-1 mutants that failed to interact with 14-3-3 isoforms (V411*, S410A, S410D) also produced only very weak macroscopic currents. In contrast, the mutant TASK-1 S409A, which interacts with 14-3-3-like wild-type channels, displayed normal macroscopic currents. Co-injection of 14-3-3ζ cRNA increased TASK-1 current in Xenopus oocytes by about 70 %. After co-transfection in HEK293 cells, TASK-1 and 14-3-3ζ (but not TASK-1ΔC5 and 14-3-3ζ) could be co-immunoprecipitated. Furthermore, TASK-1 and 14-3-3 could be co-immunoprecipitated in synaptic membrane extracts and postsynaptic density membranes. Our findings suggest that interaction of 14-3-3 with TASK-1 or TASK-3 may promote the trafficking of the channels to the surface membrane. 相似文献
68.
Gerd Geerling Norbert Koop Andreas Tüngler Ralf Brinkmann Christopher Wirbelauer Reginald Birngruber Horst Laqua 《Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft》1999,96(5):306-311
Purpose: Pulsed holmium lasers are currently used to correct hyperopia by means of laser thermokeratoplasty (LTK). Series of μs laser
pulses are applied with a high repetition rate to induce shrinkage of corneal collagen fibers. The pulsed energy application
results in intrastromal temperature peaks of up to 200 °C. A continuously emitting laser diode can – as we demonstrated recently
in an invivo study on minipigs – be used for LTK and may be of advantage because the temperature rise is more steady. The
aim of this study was to examine the safety, amount, and stability of hyperopic correction of diode LTK on blind human eyes.
Methods: We used a laserdiode that was set to continuously emit light at λ = 1.854 μm/μa = 1.04 mm–1(group I, n = 4) or 1.87 μm/μa = 1.92 mm–1 (group II, n = 4). Radiation energy was 100 to 150 mW for 10 s per coagulation. Eight coagulations on a single ring (group I) and 16 coagulations
on a double ring (group II) diameter were applied in the cornea concentric to the entrance pupil by means of a vacuum-fixed
application mask (group I = conjunctival fixation; group II = corneal fixation) and a handpiece with a focusing optic. Preoperatively
as well as 1 week, 1, 2, 3, 6 12 and 18 months postoperative ophthalmologic controls were performed and the corneal refractive
power was measured.
Results: In group I initial refractive changes of up to + 4.9 D were achieved (1 week postoperative). However, due to the great penetration
depth of the laser irradiation, large endothelial defects resulted beneath the stromal coagulations. In group II an initial
refractive change of up to + 6.8 D was achieved and as a result of the reduced penetration depth, the endothelial cell damage
was much reduced. Partial regression of the refractive effect occured in all subjects, which continued in higher refractive
changes during the 2nd postoperative year. The refractive effect at 12 months was + 0.6 to + 1.5 D in group I and + 0.9 to + 5.7 D in group II.
At 12 months the induced astigmatism was 0.5 to 2.2 D in group I and 0.3 to 1.6 D in group II. No serious adverse effects
were noticed.
Conclusion: A continously emitting laser diode working at a wavelength of 1.87 μm can be used to correct hyperopia by means of LTK safely
and effectively. Regression occurs predominantly in the first 6 postoperative months. Further studies must be conducted to
determine the importance of patient inherent parameters such as age in establishing a nomogram.
相似文献
69.
Friedrich Gönner Ralf Baumgartner Daniel Schüpbach M. C. G. Merlo 《Psychopharmacology》1999,144(4):416-418
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal side-effect of antipsychotic drug therapy, especially
of dopamine receptor antagonists. As a dose relationship has been postulated, low dose neuroleptization would be expected
to help to avoid this side-effect. In contrast, we report on a 21-year-old female following low dose fluphenazine treatment
with 2.5 mg/day. The patient recovered from NMS after 3 days of dantrolene administration. Eventually, remission from psychotic
symptoms was achieved with clozapine. At 8-month follow-up, psychopathology remained stable and there were no more signs of
NMS.
Received: 8 July 1998 / Final version: 6 November 1998 相似文献
70.
Stefan M. Haensel David L. Rowland Khalid T.H.K. Kallan Koos A. Slob 《The Journal of urology》1996,156(4):1310-1315